Ocular Therapeutix, Inc. (OCUL) Social Stream
OCULAR THERAPEUTIX INC (OCUL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering OCUL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 7 | $30 | $14 | $20.833 | $4.4 | 373.48% |
| 2022-05-09 | 6 | $30 | $14 | $20.833 | $4.4 | 373.48% |
| 2022-05-10 | 6 | $30 | $10 | $19.5 | $4.4 | 343.18% |
| 2022-05-16 | 6 | $30 | $10 | $18.833 | $4.4 | 328.02% |
| 2022-05-27 | 6 | $30 | $10 | $17.833 | $4.4 | 305.3% |
| 2022-08-08 | 6 | $30 | $5 | $16.5 | $4.4 | 275% |
| 2022-11-07 | 7 | $29 | $6.5 | $15.785 | $4.4 | 258.75% |
| 2023-01-08 | 7 | $25 | $5 | $13.285 | $4.4 | 201.93% |
| 2023-01-09 | 7 | $15 | $5 | $11.428 | $4.4 | 159.73% |
| 2023-02-13 | 7 | $15 | $5 | $11.714 | $4.4 | 166.23% |
| 2023-03-07 | 6 | $15 | $7 | $11.857 | $4.4 | 169.48% |
| 2023-05-08 | 8 | $18 | $7 | $12.625 | $4.4 | 186.93% |
| 2023-06-08 | 8 | $18 | $8 | $12.75 | $4.4 | 189.77% |
| 2023-06-13 | 8 | $15 | $8 | $12.25 | $4.4 | 178.41% |
| 2023-08-08 | 8 | $15 | $9 | $12.375 | $4.4 | 181.25% |
| 2023-11-08 | 7 | $18 | $9 | $12.857 | $4.4 | 192.2% |
| 2023-11-09 | 8 | $18 | $8 | $12.25 | $4.4 | 178.41% |
The Trend in the Analyst Price Target
OCUL's average price target has moved down $0.14 over the prior 42 months.
Over the past 43 weeks, OCUL's average upside potential has been 224.95%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-23 | 8 | 15 | 9 | 12.375 | 4.870 | 154.11% |
| 2023-08-08 | 8 | 15 | 9 | 12.375 | 3.890 | 218.12% |
| 2023-08-08 | 8 | 15 | 9 | 12.000 | 3.890 | 208.48% |
| 2023-09-14 | 7 | 18 | 9 | 12.857 | 3.610 | 256.15% |
| 2023-11-08 | 7 | 18 | 9 | 12.857 | 2.465 | 421.58% |
OCUL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
OCUL's average broker recommendation rating improved by 0.11 over the prior 45 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- OCULAR THERAPEUTIX INC's upside potential (average analyst target price relative to current price) is greater than 2741.44% of all US stocks.
- In the context of all US stocks, OCULAR THERAPEUTIX INC's average analyst price target is higher than 567.71% of them.
- To contextualize these metrics, consider that out of all US stocks, OCULAR THERAPEUTIX INC's variance in analysts' estimates is lower than -2416.99% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, OCULAR THERAPEUTIX INC's number of analysts covering the stock is greater than 2448.99% of them.
Stocks similar to OCULAR THERAPEUTIX INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ARDX, ARCT, and AVDL.
View All Top Stocks by Price Target
Make investment decisions regarding OCUL using the data that counts. Try POWR Ratings for free.